- Home
- BIAF vs IMCC Comparison
BIAF vs IMCC Comparison
Compare BIAF & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIAF | IMCC |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | Israel |
| Employees | 57 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 4.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | BIAF | IMCC |
|---|---|---|
| Price | $1.04 | $0.70 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 226.3K | 48.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | $20.04 | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.65 |
| 52 Week High | $13.50 | $7.12 |
Technical Indicators
Market Signals| Indicator | BIAF | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 27.98 |
| Support Level | $0.90 | N/A |
| Resistance Level | $1.45 | $1.55 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 28.57 | 16.27 |
Price Performance
Historical ComparisonAbout BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.